
Sabinsa Korea to showcase the Safety and Efficacy of Shelf-Stable LactoSpore™ at the Probiotic Symposium in Seoul, Korea
- Details
- Press Release
- 320
Sabinsa, the globally renowned research-oriented supplier known for its sustainable and innovative nutraceutical and cosmeceutical ingredients, will highlight LactoSpore™ Weizmannia coagulans at the Expanding the Lineup: Next Probiotics and Supplement Spring Symposium hosted by the Korean Society for Lactic Acid Bacteria and Probiotics in Seoul, Korea on May 24, 2024.

Sabinsa to Showcase Science-Backed Ingredients and Host Seminars at International Food Ingredients & Additives (IFIA) Japan Expo 2024
- Details
- Press Release
- 314
Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, will be exhibiting at the International Food Ingredients & Additives (IFIA) Expo from May 22–24, 2024, at the Tokyo Big Sight Exhibition Center. The expo primarily focuses on functional foods, dietary supplements, and natural ingredient categories, and is a significant platform for food ingredient manufacturers.

Sabinsa to Showcase C3 Reduct® - the Only EFSA-Approved Curcuminoid on the European Market – at Vitafoods Europe 2024
- Details
- Press Release
- 362
Sabinsa, the multi-national health science company founded by the late Dr. Muhammed Majeed 36 years ago, will showcase the company’s portfolio of innovative ingredients at Vitafoods Europe 2024 from 14th to 16th May, at the Palexpo SA International Exhibition Center in Geneva, Switzerland. As the official curcumin sponsor of the event, Sabinsa will highlight its revolutionary product, C3 Reduct® - the only EFSA-approved curcuminoid product in the European market.

Sabinsa to Showcase Natural Cosmeceutical Ingredients for Skin and Hair at NYSCC Suppliers’ Day
- Details
- Press Release
- 50
Sabinsa, the multi-national health science company founded by the late Dr. Muhammed Majeed 36 years ago, will introduce a new product in booth # 1418 at the New York Society of Cosmetic Chemists (NYSCC) Suppliers’ Day at the Jacob Javits Center in New York May 1 – 2, 2024. Dr. Anurag Pande, Sabinsa’s VP of Scientific Affairs, will give a presentation designed to guide those brands seeking to add natural, sustainable ingredients to their formulas.

Sami-Sabinsa Group Elevates Dr. Anju Majeed to Group Executive Chairperson, Appoints Mr. Shaheen Majeed as the new Global Managing Director & CEO
- Details
- Press Release
- 553
Sabinsa, the multi-national health science company founded by the late Dr. Muhammed Majeed 36 years ago, announces Dr. Anju Majeed as Sami-Sabinsa Group Executive Chairperson, assuming the role her father held until his death on March 13, 2024. The company also announced Shaheen Majeed as Global Managing Director & CEO.

Dr. Muhammed Majeed (September 25, 1948 – March 13, 2024) Founder , Sami-Sabinsa Group
- Details
- Press Release
- 753

Sabinsa to Highlight Research on Shagandha™ Ashwagandha for Stress Management Benefits at Expo West 2024
- Details
- Press Release
- 384
Sami-Sabinsa, the multi-national health science company founded by Dr. Muhammed Majeed 36 years ago, will be highlighting new clinical studies on Shagandha™ (Ashwagandha root extract 2.5% USP grade) for stress and anxiety in booth # 4253 at Expo West in Anaheim, CA March 13 – 16, 2024.

Sabinsa Gains First Approval for ANVISA’s IN28 in Brazil for C3 Reduct®
- Details
- Press Release
- 496
Sabinsa, the multi-national health science company founded 35 years ago by Dr. Muhammed Majeed, announces that Curcumin C3 Reduct® has been approved by the National Health Surveillance Agency in Brazil for inclusion on ANVISA’s IN28 list. This approval allows introduction and commercialization of C3 Reduct®, most active metabolite of curcumin, in food and supplements in Brazil. Approval is based on a dossier submitted to ANVISA detailing safety and efficacy of a product. C3 Reduct® is the only Tetrahydrocurcuminoids approved in this market. C3 Reduct® was given approval at dosage of 120mg/day.

Sabinsa Nanjing Expands into New Facility in Nanjing, China
- Details
- Press Release
- 558
Sabinsa, the multi-national health science company founded by Dr. Muhammed Majeed 35 years ago, will begin the new year by relocating the Sabinsa Nanjing Biotechnology Company Limited corporate office to a new location in Nanjing, China. In addition to office space, the company will have a sizeable warehouse, repacking, QC, and meeting rooms on the premises. .

Clinical Study Published on Sami-Sabinsa’s Shagandha™ Ashwagandha Shows Benefits for Stress Management in Healthy Adults
- Details
- Press Release
- 504
Sami-Sabinsa, the multi-national health science company founded by Dr. Muhammed Majeed 35 years ago, announces the most recent clinical study on its branded 2.5% USP grade Ashwagandha root ingredient: Shagandha™. The study, published in the journal Medicine, suggested that Shagandha™ can effectively reduce stress and anxiety by decreasing cortisol and increasing serotonin in healthy individuals with mild to moderate stress-related symptoms, compared to placebo.